RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Verrica Pharmaceuticals Stock

Verrica Pharmaceuticals ROA 2025

Verrica Pharmaceuticals ROA

-0.82

Ticker

VRCA

ISIN

US92511W1080

WKN

A2JPEV

In 2025, Verrica Pharmaceuticals's return on assets (ROA) was -0.82, a 49.93% increase from the -0.55 ROA in the previous year.

Verrica Pharmaceuticals Aktienanalyse

What does Verrica Pharmaceuticals do?

Verrica Pharmaceuticals Inc is a biopharmaceutical company specializing in the development of medications for various skin conditions. It was founded in 2013 and is based in West Chester, Pennsylvania. Verrica Pharm aims to develop innovative drugs for the treatment of skin nodules and warts, which can be a significant psychological burden for many patients. The business model of Verrica Pharm is based on meeting the medical needs of patients and healthcare professionals while creating value for its shareholders. The company employs a science-oriented strategy to develop a comprehensive understanding of the underlying mechanisms of skin diseases. Verrica relies on precision, science, and technology to develop and market innovative therapeutic approaches. Verrica Pharm's development programs include several product candidates at various stages of clinical development. Currently, VP-102 is the most advanced target product in Verrica's pipeline. VP-102 is a topical therapy for the treatment of condyloma and molluscum contagiosum, which is currently undergoing clinical trials. The product is offered as a plug-and-play preparation that can be easily applied to the affected skin areas without requiring additional steps. Verrica Pharm also has an extensive intellectual property (IP) portfolio that supports its research and development efforts. The portfolio includes both patents and trademarks that position the company as a leader in the treatment of skin diseases. Verrica has also established a network of partners to support its research and development activities through collaboration with other companies. Verrica Pharma has several divisions, including research and development, manufacturing, marketing, and sales. In research and development, the company focuses on identifying and developing new target molecules and therapies for various skin conditions. The research and development department is also responsible for conducting clinical trials and providing scientific evidence of the effectiveness of Verrica's therapies. In the manufacturing department, Verrica Pharm is able to produce and deliver its topicals on a large scale. The company relies on a vertically integrated value chain that encompasses all areas of production, from active ingredient synthesis to clinical testing and sales. Verrica's marketing and sales team works closely with healthcare professionals and patients to ensure widespread adoption of its products within the medical community. The company also collaborates closely with insurance companies and regulatory authorities to maximize the acceptance and distribution of its products. In summary, Verrica Pharmaceuticals has focused on the development of innovative therapies for the treatment of skin diseases. The company employs a science-oriented strategy to maximize the effectiveness of its products while building on a strong scientific foundation. With its strong pipeline, IP portfolio, and extensive marketing and distribution network, Verrica is well-positioned to meet the needs of patients and healthcare professionals and make a significant contribution to the healthcare industry. Verrica Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding Verrica Pharmaceuticals's Return on Assets (ROA)

Verrica Pharmaceuticals's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Verrica Pharmaceuticals's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Verrica Pharmaceuticals's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Verrica Pharmaceuticals’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Verrica Pharmaceuticals stock

What is the Return on Assets (ROA) of Verrica Pharmaceuticals this year?

The Return on Assets (ROA) of Verrica Pharmaceuticals is -0.82 undefined this year.

What was the ROA of Verrica Pharmaceuticals compared to the previous year?

The ROA of Verrica Pharmaceuticals has increased by 49.93% compared to the previous year.

What consequences do high ROA have for investors of Verrica Pharmaceuticals?

A high ROA is advantageous for investors of Verrica Pharmaceuticals, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in Verrica Pharmaceuticals?

A low ROA can be unfavorable for investors of Verrica Pharmaceuticals as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of Verrica Pharmaceuticals affect the company?

An increase in ROA of Verrica Pharmaceuticals can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of Verrica Pharmaceuticals impact the company?

A reduction in the ROA of Verrica Pharmaceuticals can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of Verrica Pharmaceuticals?

Some factors that can influence the ROA of Verrica Pharmaceuticals include revenue, operating costs, asset structure, and industry average.

Why is the ROA of Verrica Pharmaceuticals important for investors?

The ROA of Verrica Pharmaceuticals is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can Verrica Pharmaceuticals take to improve ROA?

To improve ROA, Verrica Pharmaceuticals can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does Verrica Pharmaceuticals pay?

Over the past 12 months, Verrica Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Verrica Pharmaceuticals is expected to pay a dividend of 0 USD.

What is the dividend yield of Verrica Pharmaceuticals?

The current dividend yield of Verrica Pharmaceuticals is .

When does Verrica Pharmaceuticals pay dividends?

Verrica Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Verrica Pharmaceuticals?

Verrica Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of Verrica Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Verrica Pharmaceuticals located?

Verrica Pharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von Verrica Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Verrica Pharmaceuticals from 2/11/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 2/11/2025.

When did Verrica Pharmaceuticals pay the last dividend?

The last dividend was paid out on 2/11/2025.

What was the dividend of Verrica Pharmaceuticals in the year 2024?

In the year 2024, Verrica Pharmaceuticals distributed 0 USD as dividends.

In which currency does Verrica Pharmaceuticals pay out the dividend?

The dividends of Verrica Pharmaceuticals are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Verrica Pharmaceuticals

Our stock analysis for Verrica Pharmaceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Verrica Pharmaceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.